Antigenic and Structural Properties of the Lipopolysaccharide of the Uropathogenic Proteus mirabilis Dm55 Strain Classified to a New O85 Proteus Serogroup.
Agata PalusiakAnna Turska-SzewczukDominika DrzewieckaPublished in: International journal of molecular sciences (2023)
The aim of the study was the serological and structural characterization of the lipopolysaccharide (LPS) O antigen from P. mirabilis Dm55 coming from the urine of a patient from Lodz. The Dm55 LPS was recognized in ELISA only by the O54 antiserum, suggesting a serological distinction of the Dm55 O antigen from all the 84 Proteus LPS serotypes described. The obtained polyclonal rabbit serum against P. mirabilis Dm55 reacted in ELISA and Western blotting with a few LPSs (including O54), but the reactions were weaker than those observed in the homologous system. The LPS of P. mirabilis Dm55 was subjected to mild acid hydrolysis, and the obtained high-molecular-mass O polysaccharide was chemically studied using sugar and methylation analyses, mass spectrometry, and 1 H and 13 C NMR spectroscopy, including 1 H, 1 H NOESY, and 1 H, 13 C HMBC experiments. The Dm55 O unit is a branched three-saccharide, and its linear fragment contains α-Gal p NAc and β-Gal p , whereas α-Glc p NAc occupies a terminal position. The Dm55 OPS shares a disaccharide epitope with the Proteus O54 antigen. Due to the structural differences of the studied O antigen from the other described Proteus O polysaccharides, we propose to classify the P. mirabilis Dm55 strain to a new Proteus O85 serogroup.
Keyphrases
- inflammatory response
- glycemic control
- mass spectrometry
- escherichia coli
- transcription factor
- anti inflammatory
- type diabetes
- lps induced
- dna methylation
- staphylococcus aureus
- case report
- metabolic syndrome
- immune response
- oxidative stress
- high resolution
- adipose tissue
- skeletal muscle
- gene expression
- cystic fibrosis
- single molecule
- gas chromatography
- water soluble
- capillary electrophoresis
- high performance liquid chromatography
- candida albicans
- tandem mass spectrometry